NEUROBO PHARMACEUTICALS INC's ticker is NRBO and the CUSIP is 64132R107. A total of 31 filers reported holding NEUROBO PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.27 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $762,000 | – | 173,202 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Mount Yale Investment Advisors, LLC | 57,425 | $191,000 | 0.02% |
FNY Investment Advisers, LLC | 10,000 | $33,000 | 0.01% |
SG3 Management, LLC | 50,000 | $167,000 | 0.01% |
PITCAIRN CO | 12,351 | $41,000 | 0.00% |
Ergoteles LLC | 30,800 | $103,000 | 0.00% |
Advisory Services Network, LLC | 8,550 | $28,000 | 0.00% |
HRT FINANCIAL LP | 18,759 | $62,000 | 0.00% |
UBS Group AG | 2,881 | $10,000 | 0.00% |
BANK OF AMERICA CORP /DE/ | 1,062 | $4,000 | 0.00% |
WELLS FARGO & COMPANY/MN | 320 | $1,000 | 0.00% |